
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer co... An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0001 | 100 | 0.0001 | 0.0002 | 0.0001 | 125186 | 0.00011591 | CS |
4 | 0.0001 | 100 | 0.0001 | 0.0002 | 1.0E-6 | 67712 | 0.00010783 | CS |
12 | -0.0001 | -33.3333333333 | 0.0003 | 0.0003 | 1.0E-6 | 153488 | 0.000127 | CS |
26 | -0.0002 | -50 | 0.0004 | 0.0187 | 1.0E-6 | 287220 | 0.00030713 | CS |
52 | -0.0113 | -98.2608695652 | 0.0115 | 0.0195 | 1.0E-6 | 254747 | 0.00421522 | CS |
156 | -0.0388 | -99.4871794872 | 0.039 | 0.0649 | 1.0E-6 | 476957 | 0.01968233 | CS |
260 | -0.1898 | -99.8947368421 | 0.19 | 0.65 | 1.0E-6 | 1220720 | 0.17177751 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions